Cargando…
Early Insights from Commercialization of Gene Therapies in Europe
Autores principales: | Touchot, Nicolas, Flume, Mathias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333067/ https://www.ncbi.nlm.nih.gov/pubmed/28218692 http://dx.doi.org/10.3390/genes8020078 |
Ejemplares similares
-
Feasibility and attractiveness of indication value-based pricing in key EU countries
por: Flume, Mathias, et al.
Publicado: (2016) -
Approaches to manage ‘affordability’ of high budget impact medicines in key EU countries
por: Flume, Mathias, et al.
Publicado: (2018) -
Investigation of Commercial Graphenes
por: Parker, Stewart F., et al.
Publicado: (2020) -
The commercial performance of cellulosic ethanol supply-chains in Europe
por: Slade, Raphael, et al.
Publicado: (2009) -
Early start of the West Nile fever transmission season 2018 in Europe
por: Haussig, Joana M., et al.
Publicado: (2018)